Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avanos Medical Inc (NY: AVNS )

23.39 +0.41 (+1.78%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250,132
Open 23.06
Bid (Size) 20.75 (1)
Ask (Size) 37.40 (1)
Prev. Close 22.98
Today's Range 22.95 - 23.55
52wk Range 19.32 - 31.99
Shares Outstanding 48,123,083
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
 
Via Benzinga
Avanos Medical Earnings Perspective: Return On Capital Employed
 
Via Benzinga

Performance

YTD
-13.72%
-13.72%
1 Month
-21.43%
-21.43%
3 Month
-17.26%
-17.26%
6 Month
-10.59%
-10.59%
1 Year
-18.50%
-18.50%

More News

Read More
Estee Lauder, NerdWallet, Sprout Social And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Recap: Avanos Medical Q1 Earnings
Via Benzinga
Looking Into Avanos Medical's Return On Invested Capital
Via Benzinga
Earnings Outlook For Avanos Medical
Via Benzinga
Recap: Avanos Medical Q3 Earnings
Via Benzinga
Avanos Medical: Q2 Earnings Insights
Via Benzinga
Avanos Medical Recalls Certain BALLARD ACCESS Closed Suction Systems For Pediatric Use Citing Ventilation Risk
Via Benzinga
Expert Ratings for Avanos Medical
Via Benzinga
7 Safe Small-Cap Stocks to Buy Now
Via InvestorPlace
7 Undervalued Small-Cap Stocks to Buy Now
Via InvestorPlace
Recap: Avanos Medical Q1 Earnings
Via Benzinga
Avanos Medical's Earnings Outlook
Via Benzinga
Recap: Avanos Medical Q4 Earnings
Via Benzinga
Avanos Medical Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Via Benzinga
Avanos Medical Earnings Preview
Via Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
Avanos Medical, inc (AVNS) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Via Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.